Paul Tudor Jones's BVS Position Overview
Paul Tudor Jones (via Tudor Investment Corp Et Al) currently holds 46,682 shares of Bioventus Inc. (BVS) worth $347,314, representing 0.00% of the portfolio. First purchased in 2021-Q1, this medium-term investment has been held for 13 quarters.
Based on 13F filings, Paul Tudor Jones has maintained a strategic position in BVS, demonstrating sustained confidence in this investment. Largest addition occurred in Q3 2024, adding 173,922 shares. Largest reduction occurred in Q2 2025, reducing 150,750 shares.
Analysis based on 13F filings available since 2013 Q2
Paul Tudor Jones's Bioventus (BVS) Holding Value Over Time
Track share changes against reported price movement
Quarterly Bioventus (BVS) Trades by Paul Tudor Jones
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +46,682 | New Buy | 46,682 | $7.44 |
| Q3 2025 | -90,641 | Sold Out | 0 | $0.00 |
| Q2 2025 | -150,750 | Reduce 62.45% | 90,641 | $6.62 |
| Q1 2025 | +30,087 | Add 14.24% | 241,391 | $9.15 |
| Q4 2024 | -45,830 | Reduce 17.82% | 211,304 | $10.50 |
| Q3 2024 | +173,922 | Add 209.01% | 257,134 | $11.95 |
| Q2 2024 | +83,212 | New Buy | 83,212 | $5.75 |
| Q3 2022 | -31,748 | Sold Out | 0 | $0.00 |
| Q2 2022 | +8,648 | Add 37.44% | 31,748 | $6.84 |
| Q1 2022 | -48,939 | Reduce 67.93% | 23,100 | $14.11 |
| Q4 2021 | +72,039 | New Buy | 72,039 | $14.49 |
| Q2 2021 | -139,009 | Sold Out | 0 | $0.00 |
| Q1 2021 | +139,009 | New Buy | 139,009 | $15.28 |
Paul Tudor Jones's Bioventus Investment FAQs
Paul Tudor Jones first purchased Bioventus Inc. (BVS) in Q1 2021, acquiring 139,009 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Paul Tudor Jones has held Bioventus Inc. (BVS) for 13 quarters since Q1 2021.
Paul Tudor Jones's largest addition to Bioventus Inc. (BVS) was in Q3 2024, adding 257,134 shares worth $3.07 M.
According to the latest 13F filing for Q4 2025, Paul Tudor Jones's firm, Tudor Investment Corp Et Al, owns 46,682 shares of Bioventus Inc. (BVS), valued at approximately $347,314.
As of the Q4 2025 filing, Bioventus Inc. (BVS) represents approximately 0.00% of Paul Tudor Jones's publicly disclosed stock portfolio, making it one of their key holdings.
Paul Tudor Jones's peak holding in Bioventus Inc. (BVS) was 257,134 shares, as reported at the end of Q3 2024.